| Code | 2076E | ||||||||||
| MA number | EU/1/13/861/004 | ||||||||||
| Product Form: | gra ent 120x300 mg (vre.PET/Al/LDPE) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Chiesi Farmaceutici S.p.A., Italy | ||||||||||
| Therapeutic Class: | 04 - AMINOACIDA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 06.09.2013 |
| SmPC + PL: |
European Medicines Agency's database
|
| Safety feature | Yes |
| Data update: | 29.09.2023 |
